Search

everythinglearnresearchcommunity

for

Search:↓

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Healthy women tend to lose more hair in July and April, and the least in February.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Many women with hard-to-treat acne also have PCOS.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Wearing a ponytail often is linked to hair loss at the front of the scalp in Chinese women.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Relatives of women with PCOS symptoms are more likely to have similar health issues.